CoChat
Sign Up
Cited by 367

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase

Fitzgerald, Marilyn L., Wang, Zihua, Park, Pyong Woo, Murphy, Gillian, Bernfield, Merton·2000·The Journal of Cell Biology
DOI 10.1083/jcb.148.4.811PMC PMC2169376
Open this paper in CoChat — free account

Abstract

The syndecan family of four transmembrane heparan sulfate proteoglycans binds a variety of soluble and insoluble extracellular effectors. Syndecan extracellular domains (ectodomains) can be shed intact by proteolytic cleavage of their core proteins, yielding soluble proteoglycans that retain the binding properties of their cell surface precursors. Shedding is accelerated by PMA activation of protein kinase C, and by ligand activation of the thrombin (G-protein–coupled) and EGF (protein tyrosine kinase) receptors (Subramanian, S.V., M.L. Fitzgerald, and M. Bernfield. 1997. J. Biol. Chem. 272:14713–14720). Syndecan-1 and -4 ectodomains are found in acute dermal wound fluids, where they regulate growth factor activity (Kato, M., H. Wang, V. Kainulainen, M.L. Fitzgerald, S. Ledbetter, D.M. Ornitz, and M. Bernfield. 1998. Nat. Med. 4:691–697) and proteolytic balance (Kainulainen, V., H. Wang, C. Schick, and M. Bernfield. 1998. J. Biol. Chem. 273:11563–11569). However, little is known about how syndecan ectodomain shedding is regulated. To elucidate the mechanisms that regulate syndecan shedding, we analyzed several features of the process that sheds the syndecan-1 and -4 ectodomains. We find that shedding accelerated by various physiologic agents involves activation of distinct intracellular signaling pathways; and the proteolytic activity responsible for cleavage of syndecan core proteins, which is associated with the cell surface, can act on unstimulated adjacent cells, and is specifically inhibited by TIMP-3, a matrix-associated metalloproteinase inhibitor. In addition, we find that the syndecan-1 core protein is cleaved on the cell surface at a juxtamembrane site; and the proteolytic activity responsible for accelerated shedding differs from that involved in constitutive shedding of the syndecan ectodomains. These results demonstrate the existence of highly regulated mechanisms that can rapidly convert syndecans from cell surface receptors or coreceptors to soluble heparan sulfate proteoglycan effectors. Because the shed ectodomains are found and function in vivo, regulation of syndecan ectodomain shedding by physiological mediators indicates that shedding is a response to specific developmental and pathophysiological cues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.148.4.811

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 84

  1. Abraham, 1996, Modulation of wound repair by members of the fibroblast growth factor family, 195
  2. Alessi, 1995, PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo, J. Biol. Chem, 270, 27489, 10.1074/jbc.270.46.27489 · DOI
  3. Amour, 1998, TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3, FEBS (Fed. Eur. Biochem. Soc.) Lett, 435, 39, 10.1016/S0014-5793(98)01031-X · DOI
  4. Anand-Apte, 1996, A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth, Biochem. Cell Biol, 74, 853, 10.1139/o96-090 · DOI
  5. Apte, 1995, The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family [published erratum appears in J. Biol. Chem. 1996. 271:2874], J. Biol. Chem, 270, 14313, 10.1074/jbc.270.24.14313 · DOI
  6. Arribas, 1996, Diverse cell surface protein ectodomains are shed by a system sensitive to metalloproteinase inhibitors, J. Biol. Chem., 271, 11376, 10.1074/jbc.271.19.11376 · DOI
  7. Bernfield, 1992, Biology of the syndecansa family of transmembrane heparan sulfate proteoglycans, Annu. Rev. Cell. Biol, 8, 365, 10.1146/annurev.cb.08.110192.002053 · DOI
  8. Bernfield, 1999, Functions of cell surface heparan sulfate proteoglycans, Annu. Rev. Biochem., 68, 729, 10.1146/annurev.biochem.68.1.729 · DOI
  9. Black, 1998, ADAMsfocus on the protease domain, Curr. Opin. Cell Biol, 10, 654, 10.1016/S0955-0674(98)80042-2 · DOI
  10. Blobel, 1997, Metalloprotease-disintegrinslinks to cell adhesion and cleavage of TNF-alpha and Notch, Cell, 90, 589, 10.1016/S0092-8674(00)80519-X · DOI
  11. Borland, 1999, Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes, J. Biol. Chem, 274, 2810, 10.1074/jbc.274.5.2810 · DOI
  12. Burridge, 1996, Focal adhesions, contractility, and signaling, Annu. Rev. Cell Dev. Biol, 12, 463, 10.1146/annurev.cellbio.12.1.463 · DOI
  13. Butler, 1997, Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases, Eur. J. Biochem, 244, 653, 10.1111/j.1432-1033.1997.t01-1-00653.x · DOI
  14. Butler, 1999, Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions, J. Biol. Chem, 274, 10846, 10.1074/jbc.274.16.10846 · DOI
  15. Butler, 1999, The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations, J. Biol. Chem, 274, 20391, 10.1074/jbc.274.29.20391 · DOI
  16. Carey, 1997, Syndecansmultifunctional cell-surface co-receptors, Biochem. J, 327, 1, 10.1042/bj3270001 · DOI
  17. Clark, 1996, The Molecular and Cellular Biology of Wound Repair
  18. Cuenda, 1995, SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1, FEBS (Fed. Eur. Biochem. Soc.) Lett, 364, 229, 10.1016/0014-5793(95)00357-F · DOI
  19. Dery, 1999, Proteinase-activated receptorsa growing family of heptahelical receptors for thrombin, trypsin and tryptase, Biochem. Soc. Trans, 27, 246, 10.1042/bst0270246 · DOI
  20. Dery, 1998, Proteinase-activated receptorsnovel mechanisms of signaling by serine proteases, Am. J. Physiol, 274, C1429, 10.1152/ajpcell.1998.274.6.C1429 · DOI
  21. Desdouits-Magnen, 1998, Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade, J. Neurochem, 70, 524, 10.1046/j.1471-4159.1998.70020524.x · DOI
  22. Dhodapkar, 1999, Syndecan-1 (CD 138) in myeloma and lymphoid malignanciesa multifunctional regulator of cell behavior within the tumor microenvironment, Leuk. Lymphoma, 34, 35, 10.3109/10428199909083378 · DOI
  23. Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. USA, 92, 7686, 10.1073/pnas.92.17.7686 · DOI
  24. Ehlers, 1991, Membrane proteins with soluble counterpartsrole of proteolysis in the release of transmembrane proteins, Biochemistry, 30, 10065, 10.1021/bi00106a001 · DOI
  25. Flaumenhaft, 1992, The extracellular regulation of growth factor action, Mol. Biol. Cell, 3, 1057, 10.1091/mbc.3.10.1057 · DOI
  26. Forsten, 1997, Endothelial proteoglycans inhibit bFGF binding and mitogenesis, J. Cell Physiol, 172, 209, 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S · DOI
  27. Gearing, 1993, Circulating adhesion molecules in disease, Immunol. Today, 14, 506, 10.1016/0167-5699(93)90267-O · DOI
  28. Gomez, 1997, Tissue inhibitors of metalloproteinasesstructure, regulation and biological functions, Eur. J. Cell Biol, 74, 111
  29. Hansen, 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunol. Methods, 119, 203, 10.1016/0022-1759(89)90397-9 · DOI
  30. Hargreaves, 1998, Human myeloma cells shed the interleukin-6 receptorinhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor, Br. J. Haematol, 101, 694, 10.1046/j.1365-2141.1998.00754.x · DOI
  31. Hodge, 1991, Humans with OKT4-epitope deficiency have a single nucleotide base change in the CD4 gene, resulting in substitution of TRP240 for ARG240, Hum. Immunol, 30, 99, 10.1016/0198-8859(91)90077-M · DOI
  32. Hooper, 1999, Membrane protein secretases, Biochem. Soc. Trans, 27, 211
  33. Hooper, 1997, Membrane protein secretases, Biochem. J, 321, 265, 10.1042/bj3210265 · DOI
  34. Izumi, 1998, A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKC-delta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor, EMBO (Eur. Mol. Biol. Organ.) J, 17, 7260, 10.1093/emboj/17.24.7260 · DOI
  35. Jalkanen, 1985, Heparan sulfate proteoglycans from mouse mammary epithelial cellslocalization on the cell surface with a monoclonal antibody, J. Cell Biol., 101, 976, 10.1083/jcb.101.3.976 · DOI
  36. Jalkanen, 1987, Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain, J. Cell Biol., 105, 3087, 10.1083/jcb.105.6.3087 · DOI
  37. Jones, 1999, C-reactive proteina physiological activator of interleukin 6 receptor shedding, J. Exp. Med, 189, 599, 10.1084/jem.189.3.599 · DOI
  38. Kainulainen, 1999, Syndecans in tissue injury
  39. Kainulainen, 1998, Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids, J. Biol. Chem, 273, 11563, 10.1074/jbc.273.19.11563 · DOI
  40. Kato, 1995, Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells, Mol. Biol. Cell, 6, 559, 10.1091/mbc.6.5.559 · DOI
  41. Kato, 1998, Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2, Nat. Med, 4, 691, 10.1038/nm0698-691 · DOI
  42. Kiessling, 1998, Transforming the cell surface through proteolysis, Chem. Biol, 5, R49, 10.1016/S1074-5521(98)90056-4 · DOI
  43. Kim, 1994, Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns, Mol. Biol. Cell, 5, 797, 10.1091/mbc.5.7.797 · DOI
  44. Kishnani, 1995, Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix, Matrix Biol, 14, 479, 10.1016/0945-053X(95)90005-5 · DOI
  45. Kraemer, 1972, Cell cycle–dependent desquamation of heparan sulfate from the cell surface, J. Cell. Biol, 55, 713, 10.1083/jcb.55.3.713 · DOI
  46. Kyriakis, 1996, Sounding the alarmprotein kinase cascades activated by stress and inflammation, J. Biol. Chem, 271, 24313, 10.1074/jbc.271.40.24313 · DOI
  47. Leco, 1994, Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues, J. Biol. Chem, 269, 9352, 10.1016/S0021-9258(17)37115-6 · DOI
  48. Lee, 1994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature, 372, 739, 10.1038/372739a0 · DOI
  49. Mali, 1994, Suppression of tumor cell growth by syndecan-1 ectodomain, J. Biol. Chem., 269, 27795, 10.1016/S0021-9258(18)46853-6 · DOI
  50. Marikovsky, 1993, Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury, Proc. Natl. Acad. Sci. USA, 90, 3889, 10.1073/pnas.90.9.3889 · DOI
  51. Mattei, 1997, Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively, Genomics, 40, 168, 10.1006/geno.1996.4559 · DOI
  52. Merlos-Suarez, 1999, Mechanisms controlling the shedding of transmembrane molecules, Biochem. Soc. Trans, 27, 243, 10.1042/bst0270243 · DOI
  53. Moss, 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha [published erratum appears in Nature. 1997. 386:738], Nature, 385, 733, 10.1038/385733a0 · DOI · Paper page
  54. Mullberg, 1997, Further evidence for a common mechanism for shedding of cell surface proteins, FEBS (Fed. Eur. Biochem. Soc.) Lett, 401, 235, 10.1016/S0014-5793(96)01480-9 · DOI
  55. Murphy, 1995, Tissue inhibitors of matrix metalloendopeptidases, Methods Enzymol, 248, 496, 10.1016/0076-6879(95)48032-3 · DOI
  56. Murphy, 1999, Mechanisms for pro matrix metalloproteinase activation, Apmis, 107, 38, 10.1111/j.1699-0463.1999.tb01524.x · DOI
  57. Odake, 1994, Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids, Biochem. Biophys. Res. Commun, 199, 1442, 10.1006/bbrc.1994.1392 · DOI
  58. Ott, 1998, Tyrosine phosphorylation of syndecan-1 and -4 cytoplasmic domains in adherent B82 fibroblasts, J. Biol. Chem, 273, 35291, 10.1074/jbc.273.52.35291 · DOI
  59. Park, 2000, Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa, J. Biol. Chem., 275, 3057, 10.1074/jbc.275.5.3057 · DOI
  60. Pavloff, 1992, A new inhibitor of metalloproteinases from chickenChIMP-3. A third member of the TIMP family, J. Biol. Chem, 267, 17321, 10.1016/S0021-9258(18)41928-X · DOI
  61. Pratt, 1998, The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement, Bioorg. Med. Chem. Lett, 8, 1359, 10.1016/S0960-894X(98)00218-2 · DOI
  62. Rapraeger, 1987, Integral Membrane Proteoglycans as Matrix ReceptorsRole in Cytoskeleton and Matrix Assembly at the Epithelial Cell Surface
  63. Reiland, 1996, Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1, Biochem. J, 319, 39, 10.1042/bj3190039 · DOI
  64. Reponen, 1995, 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation, Dev. Dyn, 202, 388, 10.1002/aja.1002020408 · DOI
  65. Ridley, 1993, Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen, Blood, 81, 767, 10.1182/blood.V81.3.767.767 · DOI
  66. Rosette, 1996, Ultraviolet light and osmotic stressactivation of the JNK cascade through multiple growth factor and cytokine receptors, Science, 274, 1194, 10.1126/science.274.5290.1194 · DOI
  67. Saunders, 1989, Molecular cloning of syndecan, an integral membrane proteoglycan, J. Cell Biol., 108, 1547, 10.1083/jcb.108.4.1547 · DOI
  68. Sayama, 1995, Effects of an antibiotic protease inhibitor, actinonin on the growth within collagen gels of non-metastatic and metastatic mouse mammary tumors of the same origin, Cancer Lett, 94, 171, 10.1016/0304-3835(95)03847-P · DOI
  69. Shin, 1991, Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4, J. Biol. Chem, 266, 10658, 10.1016/S0021-9258(18)99274-4 · DOI
  70. Spring, 1994, Drosophila syndecanconservation of a cell surface heparan sulfate proteoglycan, Proc. Natl. Acad. Sci. USA, 91, 3334, 10.1073/pnas.91.8.3334 · DOI
  71. Subramanian, 1997, Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation, J. Biol. Chem, 272, 14713, 10.1074/jbc.272.23.14713 · DOI
  72. Sutherland, 1991, Expression of syndecan, a putative low affinity fibroblast growth factor receptor, in the early mouse embryo, Development, 113, 339, 10.1242/dev.113.1.339 · DOI
  73. Thomas, 1997, Cellular functions regulated by Src family kinases, Annu. Rev. Cell. Dev. Biol, 13, 513, 10.1146/annurev.cellbio.13.1.513 · DOI
  74. Toullec, 1991, The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C, J. Biol. Chem, 266, 15771, 10.1016/S0021-9258(18)98476-0 · DOI
  75. Troyer, 1992, Stimulation of the thrombin receptor of human glomerular mesengial cells by Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe peptide, J. Biol. Chem., 267, 20126, 10.1016/S0021-9258(19)88675-1 · DOI
  76. Verheij, 1996, Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis, Nature, 380, 75, 10.1038/380075a0 · DOI
  77. Wang, 1987, Selective down modulation of L3T4 molecules on murine thymocytes by the tumor promoter, phorbol 12-myristate 13-acetate, J. Immunol, 139, 2157, 10.4049/jimmunol.139.7.2157 · DOI
  78. Werb, 1998, A cellular striptease act, Science, 282, 1279, 10.1126/science.282.5392.1279 · DOI
  79. Will, 1996, The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3, J. Biol. Chem, 271, 17119, 10.1074/jbc.271.29.17119 · DOI
  80. Wojtowicz-Praga, 1997, Matrix metalloproteinase inhibitors, Invest. New Drugs, 15, 61, 10.1023/A:1005722729132 · DOI
  81. Wolfsberg, 1996, ADAMs in fertilization and development, Dev. Biol, 180, 389, 10.1006/dbio.1996.0313 · DOI
  82. Woods, 1998, Syndecanssynergistic activators of cell adhesion, Trends Cell Biol, 8, 189, 10.1016/S0962-8924(98)01244-6 · DOI
  83. Yanagishita, 1998, Cellular catabolism of heparan sulfate proteoglycans, TIG (Trends Genet), 10, 57
  84. Yanagishita, 1992, Cell surface heparan sulfate proteoglycans, J. Biol. Chem, 267, 9451, 10.1016/S0021-9258(19)50108-9 · DOI

Cited by

Sorted by citations

Metadata

Authors
Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G., & Bernfield, M.
Affiliations
  • aDivision of Newborn Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
  • bSchool of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom
Venue
The Journal of Cell Biology
Publisher
Rockefeller University Press
Published
2000-02-21
Volume
148
Issue
4
Pages
811-824
ISSN
  • 0021-9525
  • 1540-8140
DOI
10.1083/jcb.148.4.811
PMC
PMC2169376
Cited by
367
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review